Haase, D., Stevenson, K., Neuberg, D., Maciejewski, J., Nazha, A., Sekeres, M., . . . Committee, I. W. G. F. M. M. P. (2019). TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Springer Nature.
Chicago-referens (17:e uppl.)Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.
MLA-referens (9:e uppl.)Haase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.